<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03650244</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2016/LW-01</org_study_id>
    <nct_id>NCT03650244</nct_id>
  </id_info>
  <brief_title>Nationwide Observation Study to Evaluate the Efficacy and Tolerance of the Adjustable Medical Device REMEEX® in the Treatment of Male Stress Urinary Incontinence</brief_title>
  <acronym>Remeex</acronym>
  <official_title>Nationwide Observation Study to Evaluate the Efficacy and Tolerance of the Adjustable Medical Device REMEEX® in the Treatment of Male Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We wish to set up a multicentric prospective observational study across France to collate
      data on the efficacy and tolerance of the Male REMEEX® device in patients with moderate
      stress urinary incontinence following radical prostatectomy. Patient satisfaction,
      improvement in quality of life, side effects and complications will also be studied, as will
      the ease of use of the device from the point of view of the surgeon. A long-term follow-up of
      5 years will be conducted.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2016</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomy</measure>
    <time_frame>1 month</time_frame>
    <description>PAD test &lt; 2 g / 24 h</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomy</measure>
    <time_frame>6 months</time_frame>
    <description>PAD test &lt; 2 g / 24 h</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomy</measure>
    <time_frame>1 year</time_frame>
    <description>PAD test &lt; 2 g / 24 h</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomy</measure>
    <time_frame>2 years</time_frame>
    <description>PAD test &lt; 2 g / 24 h</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomy</measure>
    <time_frame>3 years</time_frame>
    <description>PAD test &lt; 2 g / 24 h</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomy</measure>
    <time_frame>4 years</time_frame>
    <description>PAD test &lt; 2 g / 24 h</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomy</measure>
    <time_frame>5 years</time_frame>
    <description>PAD test &lt; 2 g / 24 h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Normal clinical examination</measure>
    <time_frame>month 1</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normal clinical examination</measure>
    <time_frame>Month 6</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normal clinical examination</measure>
    <time_frame>Year 1</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normal clinical examination</measure>
    <time_frame>Year 2</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normal clinical examination</measure>
    <time_frame>Year 3</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normal clinical examination</measure>
    <time_frame>Year 4</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normal clinical examination</measure>
    <time_frame>Year 5</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary output</measure>
    <time_frame>Month 1</time_frame>
    <description>ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary output</measure>
    <time_frame>Month 6</time_frame>
    <description>ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary output</measure>
    <time_frame>year 1</time_frame>
    <description>ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary output</measure>
    <time_frame>year 2</time_frame>
    <description>ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary output</measure>
    <time_frame>year 3</time_frame>
    <description>ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary output</measure>
    <time_frame>year 4</time_frame>
    <description>ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary output</measure>
    <time_frame>year 5</time_frame>
    <description>ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of urine</measure>
    <time_frame>month 1</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of urine</measure>
    <time_frame>month 6</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of urine</measure>
    <time_frame>year 1</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of urine</measure>
    <time_frame>year 2</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of urine</measure>
    <time_frame>year 3</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of urine</measure>
    <time_frame>year 4</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of urine</measure>
    <time_frame>year 5</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual urine volume</measure>
    <time_frame>Month 1</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual urine volume</measure>
    <time_frame>Month 6</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual urine volume</measure>
    <time_frame>year 1</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual urine volume</measure>
    <time_frame>year 2</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual urine volume</measure>
    <time_frame>year 3</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual urine volume</measure>
    <time_frame>year 4</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual urine volume</measure>
    <time_frame>year 5</time_frame>
    <description>ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystoscopy</measure>
    <time_frame>Month 1</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystoscopy</measure>
    <time_frame>Month 6</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystoscopy</measure>
    <time_frame>year 1</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystoscopy</measure>
    <time_frame>year 2</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystoscopy</measure>
    <time_frame>year 3</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystoscopy</measure>
    <time_frame>year 4</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cystoscopy</measure>
    <time_frame>year 5</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readjustment of the REMEEX medical device</measure>
    <time_frame>Month 1</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readjustment of the REMEEX medical device</measure>
    <time_frame>Month 6</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readjustment of the REMEEX medical device</measure>
    <time_frame>Year 1</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readjustment of the REMEEX medical device</measure>
    <time_frame>Year 2</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readjustment of the REMEEX medical device</measure>
    <time_frame>Year 3</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readjustment of the REMEEX medical device</measure>
    <time_frame>Year 4</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readjustment of the REMEEX medical device</measure>
    <time_frame>Year 5</time_frame>
    <description>Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General improvement of symptoms</measure>
    <time_frame>1 month</time_frame>
    <description>Patient Global Impression of Improvement Questionnaire (PGI-I)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General improvement of symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>Patient Global Impression of Improvement Questionnaire (PGI-I)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General improvement of symptoms</measure>
    <time_frame>1 year</time_frame>
    <description>Patient Global Impression of Improvement Questionnaire (PGI-I)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General improvement of symptoms</measure>
    <time_frame>2 years</time_frame>
    <description>Patient Global Impression of Improvement Questionnaire (PGI-I)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General improvement of symptoms</measure>
    <time_frame>3 years</time_frame>
    <description>Patient Global Impression of Improvement Questionnaire (PGI-I)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General improvement of symptoms</measure>
    <time_frame>4 years</time_frame>
    <description>Patient Global Impression of Improvement Questionnaire (PGI-I)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General improvement of symptoms</measure>
    <time_frame>5 years</time_frame>
    <description>Patient Global Impression of Improvement Questionnaire (PGI-I)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary symptoms</measure>
    <time_frame>1 month</time_frame>
    <description>Urinary Symptom Profile Questionnaire (USP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>Urinary Symptom Profile Questionnaire (USP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary symptoms</measure>
    <time_frame>1 year</time_frame>
    <description>Urinary Symptom Profile Questionnaire (USP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary symptoms</measure>
    <time_frame>2 years</time_frame>
    <description>Urinary Symptom Profile Questionnaire (USP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary symptoms</measure>
    <time_frame>3 years</time_frame>
    <description>Urinary Symptom Profile Questionnaire (USP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary symptoms</measure>
    <time_frame>4 years</time_frame>
    <description>Urinary Symptom Profile Questionnaire (USP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary symptoms</measure>
    <time_frame>5 years</time_frame>
    <description>Urinary Symptom Profile Questionnaire (USP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects or complications</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects or complications</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects or complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects or complications</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects or complications</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects or complications</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects or complications</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability and ease of use of the device</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability and ease of use of the device</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability and ease of use of the device</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability and ease of use of the device</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability and ease of use of the device</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability and ease of use of the device</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reliability and ease of use of the device</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient incontinence-related quality of life</measure>
    <time_frame>1 month</time_frame>
    <description>Incontinence Quality of Life Questionnaire (I-QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient incontinence-related quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Incontinence Quality of Life Questionnaire (I-QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient incontinence-related quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>Incontinence Quality of Life Questionnaire (I-QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient incontinence-related quality of life</measure>
    <time_frame>2 years</time_frame>
    <description>Incontinence Quality of Life Questionnaire (I-QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient incontinence-related quality of life</measure>
    <time_frame>3 years</time_frame>
    <description>Incontinence Quality of Life Questionnaire (I-QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient incontinence-related quality of life</measure>
    <time_frame>4 years</time_frame>
    <description>Incontinence Quality of Life Questionnaire (I-QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient incontinence-related quality of life</measure>
    <time_frame>5 years</time_frame>
    <description>Incontinence Quality of Life Questionnaire (I-QOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sexual-related quality of life</measure>
    <time_frame>1 month</time_frame>
    <description>International Index of Erectile Function (IIEF-5) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sexual-related quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>International Index of Erectile Function (IIEF-5) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sexual-related quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>International Index of Erectile Function (IIEF-5) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sexual-related quality of life</measure>
    <time_frame>2 years</time_frame>
    <description>International Index of Erectile Function (IIEF-5) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sexual-related quality of life</measure>
    <time_frame>3 years</time_frame>
    <description>International Index of Erectile Function (IIEF-5) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sexual-related quality of life</measure>
    <time_frame>4 years</time_frame>
    <description>International Index of Erectile Function (IIEF-5) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sexual-related quality of life</measure>
    <time_frame>5 years</time_frame>
    <description>International Index of Erectile Function (IIEF-5) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of use by the surgeon.</measure>
    <time_frame>Day 0</time_frame>
    <description>anological visual scale (between 0 and 10)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Urinary Incontinence,Stress</condition>
  <arm_group>
    <arm_group_label>Patients fitted with REMEEX</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>REMEEX implantation</intervention_name>
    <description>Device implantation</description>
    <arm_group_label>Patients fitted with REMEEX</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 suffering from moderate stress incontinence (pure or predominant)
        following radical prostatectomy surgery for prostate cancer, for at least 12 months,
        unresolved after of pelvic floor reeducation, regardless of the surgical procedure used or
        of treatment with radiotherapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has been informed about the study

          -  The patient is at least 18 years old

          -  Patient suffering from moderate stress incontinence (pure or predominant) following
             radical prostatectomy surgery, for at least 12 months, unresolved after of pelvic
             floor reeducation

          -  Patient scheduled for REMEEX® implant

        Exclusion Criteria:

          -  It proves impossible to give the patient clear information

          -  Patient refuses to participate

          -  Life expectancy of the patient estimated to be less than the 5 year follow-up

          -  Impossible to contact patient after hospitalization

          -  Radiotherapy of less than 6 month

          -  Patient unable to fill in questionnaire

          -  Incapably of performing pad test at 24 hours

          -  Recurrent symptomatic prostate cancer

          -  Mixed incontinence with urgency incontinence

          -  Bladder outlet obstruction: stenosis of the vesico-urethral anastomosis or untreated
             urethral stricture.

          -  Post void residual &gt;100ml

          -  Other cancer under treatment or progressing

          -  Kidney injury, hepatocellular insufficiency

          -  Auto-immune disease

          -  Neurological-origin urinary incontinence (stroke, MS, Parkinson's)

          -  Incontinence arising from surgery other than prostatectomy

          -  recurrent gross hematuria

          -  Recurrent urinary infection

          -  Bladder stones
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chabannes, MD</last_name>
      <email>echabannes@chu-besancon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP Hôpital Henry Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rene Yiou, MD</last_name>
      <email>yiourene@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Mourey, MD</last_name>
      <email>eric.mourey@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Descazeaux, MD</last_name>
      <email>aurelien.descazeaud@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lemelle, MD</last_name>
      <email>jl.lemelle@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Hubert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lecoanet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Chevalier, MD</last_name>
      <email>chevalier.d@chu-nice.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Wagner, MD</last_name>
      <phone>+33 (0)6 16 57 02 07</phone>
      <email>laurent.wagner@chu-nimes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Saussine, MD</last_name>
      <email>christian.saussine@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cour, MD</last_name>
      <email>f.cour@hopital-foch.org</email>
    </contact>
    <investigator>
      <last_name>Vidart, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Game, MD</last_name>
      <email>game.x@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>August 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2018</study_first_posted>
  <last_update_submitted>August 27, 2018</last_update_submitted>
  <last_update_submitted_qc>August 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

